BUPROPION News
BUPROPION currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for BUPROPION with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (20):
- dysthymic disorder (99.0%)
- unipolar depression (99.0%)
- monogenic obesity (99.0%)
- anxiety disorder (99.0%)
- obesity disorder (99.0%)
- major affective disorder (99.0%)
- major depressive disorder (99.0%)
- nicotine dependence (99.0%)
- endogenous depression (99.0%)
- neurotic disorder (99.0%)
- attention deficit-hyperactivity disorder (100.0%)
- attention deficit hyperactivity disorder, inattentive type (100.0%)
- faciodigitogenital syndrome (100.0%)
- specific developmental disorder (100.0%)
- chondromyxoid fibroma (100.0%)
- proximal 16p11.2 microdeletion syndrome (99.8%)
- hypervitaminosis (99.7%)
- benign paroxysmal torticollis of infancy (99.5%)
- trigeminal nerve neoplasm (99.3%)
- obsolete hypertelorism (disease) (99.3%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.